Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma

Anticancer Research

Volumn 18, Issue 3 B, 1998, Pages 2063-2068

  Linder, Christina ^a   Linder, Stig ^a   Munck Wikland, Eva ^a   Strander, Hans ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Angiogenesis; bFGF; Serum markers; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HEAD CANCER; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; NECK CANCER; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SARCOMA;

EID: 0031879683     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
2. Folkman J and Shing Y: Angiogenesis. J Biol Chem 267: 10931-10933, 1992.
3. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1: 27-31, 1995.
4. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887, 1992.
5. Gasparini G and Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncology 13: 765-782, 1995.
6. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K and Harris AL: Angiogenesis, assessed by platelet/ endothelial cell adhesion molecule antibodies, an indicator of node metastases and survival in breast cancer. The Lancet 340: 1120-1124, 1992.
7. Kolch W, Martiny-Baron G, Kieser A and Marme D: Regulation of the expression of the VEGF/VPF and its receptors: role in tumor angiogenesis. Breast Cancer Res & Treat 36: 139-155, 1995.
8. Zhang HT, Craft P, Scott PA, Ziehe M, Weich HA, Harris AL and Bicknell R: Enhancement of tumor growth and vascular density by transfection of vacular endothelial growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 87: 213 -219, 1995.
9. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Brxton L, Hillan KJ and Moore MW: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442, 1996.
10. Basilico C and Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Research 59: 115-165, 1992.
11. Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, YO, Kikuchi H and MH: Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA 87: 5710-5714, 1990.
12. Wu D, Kan M, Sato GH, Okamoto T and Sato JD: Characterization and molecular cloning of a putative binding protein for heparin-binding growth factor. J Biol Chem 266: 16778-16785, 1991.
13. Czubayko F, Liaudet-Coopman EDE, Aigner A, Tuveson AT, Berchem GJ and Wellstein A: A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nature Medicine 3: 1137-1140, 1997.
14. Toi M, Hoshina S, Takayanagi T and Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045-1049, 1994.
15. Gasparini G, Toi M, Gion M, Verderio P, Dittadi R, Hanatani M, Matsubara I, Vinante O, Bonoldi E, Borrachi P, Gatti C, Suzuki H and Tominaga T: Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 89: 139147, 1997.
16. Toi M, Tanaguchi T, Yamamoto Y, Kurisaki T, Suzuki H and Tominaga T: Clinical significance of the determination of angiogenic factors. Eur J Cancer 32A: 2513-2519, 1996.
17. Visscher DW, DeMattia F, Ottosen S, Sarkar FH and Crissman JD: Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma. Modern Pathology 8: 665-670, 1995.
18. Linder C, Bystrom P, Engel G, Auer G, Strander H and Linder S: Correlation between basic fibroblast growth factor immunostaining of stromal cells and stromelysin-3 mRNA expression in human breast carcinoma. Br J Cancer, in press.
19. Watanabe H, Nguyen M, Schizer M, Li V, Hayes DF, Sallan S and Folkman J: Basic fibroblast growth factor in human serum - a prognostic test for breast cancer. Mol Biol Cell (suppl.) 3: 234, 1992.
20. Sliutz G, Tempfer C, Obsermair A, Reinthaller A, Gitsch G, and Kainz C: Serum evaluation of basic fibroblast growth factor in cervical cancer patients. Cancer letts 94: 227-231, 1995.
21. Fujimoto K, Ichimori Y, Kakizoe T, Okajima E, Sakamoto H, Sugimura T and Terada M: Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem Biophys Res Comm 180: 386-392, 1991.
22. Duensing S, Grosse J and Atzpodien J: Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patients. Anticancer Res 15: 2331-2334, 1995.
23. Heits F, Katschinsky DM, Wiedemann GI, Weiss C and Jelkman W: Serum vascular endothelial growth factor (VEGF), a prognostic indicator in sarcoma and carcinoma patients. Int J Oncology 10: 333-337, 1997.
24. Kondo S, Asano M, Matsuo K, Ohmori I and Suzuki H: Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta, 1994.
25. Dirix LY, Vermeulen PB, Pawinski A, Prové A, Benoy I, de Pooter C, Martin M and van Oosterom AT: Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 76: 238-243, 1997.
26. Goto F, Goto K, Weindel K and Folkman J: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69: 508-517, 1993.
27. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF and Isner JM: Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92: 365-371, 1995.
28. Singh RK, Gutman M, Bucana CD, Sanchcz R, Llansa N and Fidler IJ: Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 92: 4562-4566, 1995.
29. Barbareschi M, Gasparini G, Morelli L, Forti S and Dalla Palma P: Novel methods for the determination of the angiogenic activity of human tumors. Breast Cancer Res and Treat 36: 181-192, 1995.